Toxic preservatives, function

Design new products that preserve functionality while reducing toxicity. 

Principle 4 Design New Products That Preserve Functionality While Reducing Toxicity... 

Surfactants. The use of surfactants is greatly restricted in formulating ophthalmic solutions. The order of surfactant toxicity is anionic > cationic >> nonionic. Several nonionic surfactants are used in relatively low concentrations to aid in dispersing steroids in suspensions and to achieve or to improve solution clarity. Those principally used are the sorbitan ether esters of oleic acid (Polysorbate or Tween 20 and 80), polymers of oxyethylated octyl phenol (Tyloxapol), and polyoxyl 40 stearate. The lowest concentration possible is used to perform the desired function. Their effect on preservative efficacy and their possible binding by macromolecules must be taken into account, as well as their effect on ocular irritation. The use of surfactants as cosolvents for an ophthalmic solution of chloramphenicol has been described [271]. This com-... 

Chemical products should be designed to preserve efficacy of function while reducing toxicity. 

The relatively acidic thiol on serum albumin forms a fairly stable S-nitroso adduct with nitric oxide, which may serve to preserve and carry NO throughout the circulatory system [162,163]. Bacterial toxins released in toxic-shock syndrome induce excessive NO-synthase activity in macrophages. The resulting arterial expansion may induce the cardiovascular collapse associated with toxic shock syndrome [164]. Nitrous acid reacts with DNA to form dG-N2-dG interstrand crosslinks at the sequence 5 CG [165]. NO can also deaminate cytidine [166] and deoxyguanosine [167] and so may function as a mutagen. The rate law for NO reacting with O2 has been measured electrochemically as [168] ... 

Both e-aminocaproic acid and tranexamic acid may improve haemostasis by a combination of inhibition of fibrinolysis, reduced release of tPA, and preservation of platelet function. Tranexamic acid is more potent and has the same low toxicity as -aminocaproic acid and the latter is now seldom used and is no longer registered for clinical use in many countries. 

---